Therapeutic Expertise

Ten therapeutic areas. One standard: deep market expertise.
Spherix is built around therapeutic area specialists with extensive experience covering the indications, competitive dynamics, and commercial inflection points that define each market. Combined with continuous primary research and AI-enhanced analysis, they deliver insights grounded in both expertise and evidence.

Therapeutic Expertise

That is what separates Spherix from other vendors. The research behind every product provides the evidence. Our franchise teams provide the interpretation, context, and commercial judgment that turn that evidence into action – for launch strategy, competitive response, pipeline planning, and market access. AI generates more information than ever before. The real advantage comes from knowing what matters, what is noise, and what your team should do next.

Cardiovascular-Kidney-Metabolic Disease

Jim Hickey

Franchise Head

Kari McCarthy

Franchise Head

Dermatology

Andy Stankus

Franchise Head

Gastroenterology

Jim Hickey

Franchise Head

Hematology

Sarah Hendry

Franchise Head

Nephrology

Kari McCarthy

Franchise Head

Neuroscience (CNS)

Sarah Soucy

Franchise Head

Oncology

Sarah Hendry

Franchise Head

Ophthalmology

Sarah Soucy

Franchise Head

Respiratory

Andy Stankus

Franchise Head

Rheumatology

Lynn Price

Franchise Head

Fully dedicated Market Access expertise

Eleven dedicated Market Access subject matter experts. 75+ years combined experience. 20+ primary research studies and 120+ account profiles published annually. Sybil Mead, Vice President of Market Access, leads the team.